Science Current Events | Science News | Brightsurf.com
 

Lack of a key enzyme dramatically increases resistance to sepsis

April 24, 2006

Findings could lead to new therapeutic approaches to a major disease

According to the new study, the presence of caspase-12, which appears to modulate inflammation and innate immunity in humans, increases the body's "vulnerability to bacterial infection and septic shock" while a deficiency confers strong resistance to sepsis. This new discovery suggests that caspase-12 antagonists could be a potentially useful in the treatment of sepsis and other inflammatory and immune disorders.

The study was published in the April 20 edition of the journal Nature (Volume 440, Number 7087).

Richard Ulevitch, chair of the Scripps Research Immunology Department and an author of the paper, says, "The results of the study make clear that caspase-12 plays a critical role in the elimination of bacterial pathogens, and that a deficiency allows systemic and abdominal infections to be better resolved. It's known that the presence of caspase-12 as a full length protein occurs in a small percentage of people of African descent. As a result, some of these individuals are far more susceptible to severe sepsis and have a significantly increased risk of dying from it."

Sepsis, the body's inflammatory response to severe infection, is one of the leading causes of death in the United States, killing more than 200,000 people each year, according to the Society of Critical Care Medicine. A 2003 study by The Centers for Disease Control and Emory University School of Medicine showed that the incidence of sepsis in the United States has increased almost nine percent a year since 1979.

The new study showed that caspase-12 deficient mice were resistant to peritonitis and septic shock and were able to clear pathogenic bacteria more efficiently than mice with the enzyme. The presence of caspase-12 also reduced production of several pro-inflammatory cytokines, increasing vulnerability to bacterial infection and septic mortality.

"Without the experimental model of peritonitis perfected by John Mathison from Scripps Research, we would not have been able to differentiate between the two mouse phenotypes," Ulevitch said. "Because of his work, we were able to use a surgically implanted stent in the colon that allowed a gradual occurrence of sepsis and easy identification."

A majority of mice with caspace-12 died from sepsis within the first 48 hours after onset, while 60 percent of the caspase-12 deficient mice survived. The deficient mice also showed a significantly lower number of bacterial colony-forming units per milliliter of blood, suggesting that more efficient bacterial clearance occurs in the absence of caspase-12.

Caspase-12 is also an inhibitor of caspase-1, a related enzyme involved in the inflammation process. Caspase-1 deficient mice are two-to-three times more susceptible to lethal Escherichia coli infection than normal mice. Consequently, the study said, sepsis resistance in caspase-12 deficient mice was most likely due to an initial hyper-production of cytokines that fight the infection.

"The resulting beneficial effect of cytokine hyper-production runs contrary to some of the current thinking in sepsis research," Ulevitch said. "The general thinking is that this initial cytokine 'storm' is harmful, and that belief has been the basis of a number of unsuccessful clinical studies. In our study, cells containing caspase-12 appear to weaken the activity of caspase-1 that is normally essential for bacterial clearance and sepsis survival."

In another finding, researchers showed that both mouse models had similar levels of stress-induced apoptosis or programmed cell death. While caspase-12 was previously thought to be a key mediator of endoplasmic reticulum apoptosis, the new study found that the presence or absence of caspase-12 had no effect on apoptotic sensitivity whatsoever.

Others authors of the study include Maya Saleh (currently with McGill University), Melissa K. Wolinski, Steve J. Bensinger, Patrick Fitzgerald, Nathalie Droin, Douglas R. Green (La Jolla Institute of Allergy and Immunology and St. Jude Children's Research Hospital); Donald W. Nicholson of Merck Research Laboratories, and; John C. Mathison of Scripps Research.

Scripps Research Institute


Related Sepsis Current Events and Sepsis News Articles


Targeted antibiotics may help protect against infections in men being tested for prostate cancer
A new review indicates that antimicrobial therapy given before clinicians take transrectal ultrasound-guided prostate biopsies to diagnose prostate cancer may lead to lower rates of sepsis, a potentially life-threatening infection.

Study found adding azithromycin to standard antibiotic reduced infections in C-sections
A cephalosporin antibiotic has been used as the standard to prevent infections in women undergoing cesarean delivery; however, this study looked at using azithromycin as an additional antibiotic.

Most cases of brain-damaged newborns not due to mismanaged deliveries
A study by researchers at Loyola University Medical Center and Loyola University Chicago is providing new evidence that the vast majority of babies who are born with severe brain damage are not the result of mismanaged deliveries.

Sepsis: Cell therapy to repair muscle long-term impairment
Scientists from the Institut Pasteur, Paris Descartes University, Sainte-Anne Hospital and the CNRS have recently published a paper in Nature Communications in which they reveal mayor players in the severe muscle damage caused by sepsis, or septicemia, which explains why many patients suffer debilitating muscle impairment long-term after recovery.

Rapid molecular assay may help diagnose sepsis
Measuring the levels of RNA biomarkers in blood may help quickly differentiate sepsis from infection-negative systemic inflammation, according to research published this week in PLOS Medicine.

Aspirin targets key protein in neurodegenerative diseases
A new study finds that a component of aspirin binds to an enzyme called GAPDH, which is believed to play a major role in neurodegenerative diseases, including Alzheimer's, Parkinson's and Huntington's diseases.

New gene a key to fighting sepsis
Scientists have identified a gene that could potentially open the door for the development of new treatments of the lethal disease sepsis.

Advances made against the deadly infection complication, sepsis
Sepsis is an inflammatory response to infection that's known to develop in hospital settings and can turn deadly when it's not discovered early on.

Early ID of physiological deterioration and appropriate care improves sepsis outcomes
Researchers from Brooke Army Medical Center in San Antonio, Texas, evaluated the rapid response system (RRS) training program on call rates and code blue events and found significant improvements were made in staff awareness and patient outcomes.

Sepsis and shock response team in the ED reduces mortality
Researchers from Mayo Clinic in Jacksonville, Florida, formed a multidisciplinary sepsis and shock response team (SSRT) to help alert emergency department providers when these disorders are suspected.
More Sepsis Current Events and Sepsis News Articles

Sepsis: Diagnosis and Treatment

Sepsis: Diagnosis and Treatment
by NetCE


The purpose of this course is to provide healthcare professionals with evidence-based recommendations so they may optimally manage the patient who presents with sepsis and septic shock and minimize adverse outcomes. In addition, members of the public may use this course to enhance their personal knowledge of the subject matter presented.

Upon completion of this course, you should be able to:

1. Define the various degrees of sepsis, and describe the history and incidence of sepsis relative to mortality.
2. List the risk factors associated with the development of sepsis.
3. Describe the pathogenesis of SIRS, including the five phases of development, and the pathophysiology of sepsis.
4. List potential organ manifestations related to the...

Sepsis

Sepsis


Rhys Ireland, a jack of all failures, stands on the precipice of suicide between the borders of Washington and Oregon; staring deep into the dark waters of the Columbia River at midnight. His next decision will change the world...irreparably.

The following morning, traveling to his favorite spot near Bonneville Dam, all retiree Graham Myers wants is an exciting day of sturgeon fishing Lord willing. The catch of the day proves entirely too exciting.

Nearby in the small town of North Bonneville, Trooper Janus Bradley, of the Washington State Patrol, is still bitter from the aftermath of a nasty divorce. Responding to a disturbance at the upscale hot springs resort, he bears witness to the beginning of the end.

Concurrently, fifteen year-old Aria...

Gyroscope- A Survival of Sepsis

Gyroscope- A Survival of Sepsis
by Gary Black (Author)


Gyroscope is a compelling and inspiring true story about a miraculous survival of sepsis. It reveals and illustrates the innermost traumas and triumphs of a journey through this devastating illness.

Actual book size is 6 x 9

Sepsis and Septic Shock

Sepsis and Septic Shock


Sepsis and Septic Shock

Last updated: 9/30/12, 5/21/13
Number of questions: 12

Sepsis: Diagnosis, Management and Health Outcomes (Allergies and Infectious Diseases)

Sepsis: Diagnosis, Management and Health Outcomes (Allergies and Infectious Diseases)
by Nancy, M.D., Ph.D. Khardori (Editor)




My Sepsis Story: How I Almost Died and You Don't Have To

My Sepsis Story: How I Almost Died and You Don't Have To
by Lisa Brandt Creative Services


I am not a doctor. But when everyone, including a doctor, said I had the flu, I knew it was something more. I'm a survivor of sepsis. Chances are, you aren't familiar with sepis, but it kills more people than cancer and is more common than heart attack. And I want you to know about it so you can avoid what I went through. My story is anything but a Debbie Downer tale. After all, you already know it has a happy ending.

Emergency Medicine: Sepsis (Audio-Digest Foundation Emergency Medicine Continuing Medical. Volume 31, Issue 20)

Emergency Medicine: Sepsis (Audio-Digest Foundation Emergency Medicine Continuing Medical. Volume 31, Issue 20)


Purpose: Audio-Digest Foundation CME/CE activities are designed to provide its learners – physicians and other healthcare professionals – with continuing education that will help identify clinical problems in their practice settings, provide content to help to solve those problems, and increase their application of knowledge to practice.

Audio-Digest Emergency Medicine is specifically designed to provide the participant with state-of-the-art information, including, but not limited to, the care of patients presenting to the emergency department in such areas as:

Airway management
Asthma
Bite wounds
Burns
Cardiovascular emergencies
Domestic violence
Drug abuse
Envenomations
Infectious diseases
The Sepsis Text

The Sepsis Text
by Jean-Louis Vincent (Editor), Jean Carlet (Editor), Steven M. Opal (Editor)


This textbook is written at the dawn of a new era in the management of sepsis. Recent achievements in the clinical management of septic shock are the culmination of decades of basic and applied research by innovative researchers and clinical investigators worldwide. The contributing authors to this book have spearheaded much of this research and the Editors have endeavored to create a textbook that is comprehensive in nature while maintaining a specific focus upon the multitude of work that constitutes the spectrum of sepsis research including: pathophysiology; monitoring systems; general support; microbial aspects; complications; and anti-sepsis therapies.

Sepsis

Sepsis
by Guillermo Ortiz-Ruiz (Editor), Marco A. Perafan (Editor), Eugen Faist (Editor), Carmelo Dueñas Castell (Editor)


Sepsis (or septic shock) is one of the leading post-surgical or post-traumatic complications in today's hospitals. This pervasive condition is the major cause of morbidity and mortality in intensive care units worldwide, as well as the leading cause of death in non-coronary patients. This is a concise, practical soft cover volume devoted to covering only the most practical information for physicians. Charts, tables, and other figures are used to illustrate easy-to-follow treatment guidelines for those professionals who regularly treat patients in the ICU.

Pathophysiology of Shock, Sepsis, and Organ Failure

Pathophysiology of Shock, Sepsis, and Organ Failure
by Günther Schlag (Editor), Heinz Redl (Editor)


In this book current knowledge of the pathophysiology of shock, sepsis and multi organ failure is presented. The rapid progress which has been made and the results achieved in intensive care medicine are based on sound basic research, which is duly reflected in these chapters. Multiorgan failure is the foremost cause of postoperative and posttraumatic death and many complex mechanisms are involved. Only with a good foundation of basic research can abnormalities in the physiological, biochemical, and morphological course of shock be recognized and the necessary conclusions for treatment drawn. Therapy must proceed from profound knowledge of the multi variant physiological events in order to influence shock, sepsis and organ failure. Although numerous possibilities for therapy have arisen...

© 2016 BrightSurf.com